TRDA
Entrada Therapeutics, Inc.
Key Financials
Operating Income
$-157898000
↓ 435.9%
Net Income
$-143750000
↓ 319.0%
Revenue
$25.4M
↓ 87.9%
Total Assets
$377.4M
↓ 28.3%
Total Liabilities
$71.2M
↓ 27.0%
EPS (Diluted)
$-3.47
↓ 306.5%
Shareholders' Equity
$306.1M
↓ 28.6%
Cash & Equivalents
$90.4M
↓ 10.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/2/2026 | View on SEC |
| 144 | 4/1/2026 | View on SEC |
| 4 | 3/11/2026 | View on SEC |
| 4 | 3/11/2026 | View on SEC |
| 144 | 3/9/2026 | View on SEC |
| 144 | 3/9/2026 | View on SEC |
| 4 | 3/6/2026 | View on SEC |
| 144 | 3/4/2026 | View on SEC |
| 4 | 3/3/2026 | View on SEC |
| 4 | 3/3/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TRDA |
| Company Name | Entrada Therapeutics, Inc. |
| CIK | 1689375 |
| Sector | Pharmaceutical Preparations |
| Industry | Accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 857-305-1825 |